Skip to main content
Todd Zywicki on Muck Rack

Todd Zywicki

Arlington, Washington, D.C.
As seen in: Cato Institute, MSN, Forbes, The Wall Street Journal, The Washington Post, USA Today, Washington Post Opinions, Yahoo News, Aol, Newsweek, Yahoo Finance and
George Mason University Foundation Professor of Law, Antonin Scalia Law School
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Todd

Contact Todd, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Don’t Let Banks Charge Data-Rationing Fees

|
By Todd Zywicki
| National Review Verified
The Consumer Financial Protection Bureau is considering allowing banks to impose volume-based fees, also known as data rationing, when consumers use third-party financial applications to access their own financial data. That would be a serious mistake.
Open in Who Shared Issue with article?

AI Privilege: Code May Matter More Than Courts

|
By Mikołaj Barczentewicz, Jeffrey Westling, Todd Zywicki
TL;DR TL;DR Background: OpenAI CEO Sam Altman has called for an “AI privilege,” arguing that users often confide in AI services much as they do in doctors, lawyers, or therapists. Yet ordinary AI chats generally receive no comparable legal protection. Courts may therefore order their disclosure when they are relevant to a lawsuit, whether the user is a party or the provider itself becomes a target, as in New York Times v. OpenAI.
Open in Who Shared Issue with article?

MFN Drug Pricing: Importing the Wrong Cure

|
By Kristian Stout, Todd Zywicki, Ben Sperry
TL;DR TL;DR Background: U.S. patients pay more than patients in other wealthy countries for the same branded prescription drugs. Supporters of most-favored-nation (MFN) pricing treat that gap as proof Americans overpay, and propose tying U.S. reimbursement to foreign prices. The idea has moved from a blocked 2020 Medicare rule into today’s trade debate.
Open in Who Shared Issue with article?
See all 183 licensed articles (199 Total)